High technology to every breast cancer patient.
Mammi is a dedicated breast PET with unprecedented clinical resolution able to visualize tumors down to 2 mm, which is essential for early breast cancer detection.
Its imaging technology can identify small lesions with more accuracy than other conventional techniques.
Mammi provides an extraordinary definition and characterization of lesions, active areas of heterogeneous tumors and tumor limits. Ideal to be more specific in the treatments, planning surgeries with accuracy and monitoring the response during neoadjuvant treatments.
The natural prone position, with no breast compression, together with a ring configuration, provides optimum patient comfort, enhances sensitivity and detection of difficult lesions.
True 3D high-resolution images that helps in complex cases (previous surgeries, dense breast, etc.). Reduces false negatives from WBPET and false positives from MRI.
Mammi provides tumor’s metabolic activity, shape, size and accurate SUV quantification: critical for optimizing personalized treatments.
Mammi’s high-resolution imaging visualizes intratumoral heterogeneity. This level of accuracy is impossible to visualize in WBPET.
Thanks to it’s high sensitivity ring geometry, lower doses can be used, allowing secure, accurate, and multiple scans with minimal radiation exposure to patients and technicians.
Prone position and no breast compression allow a comfortable breast examination. Double ring provides faster image acquisitions to scan more patients in the same time. In addition, it’s easy to use and has a fast learning curve thanks to its intuitive and user-friendly software.
Mammi allows the visualization of tumors down to 2 mm, which is essential for early breast cancer detection and metabolic activity visualization of breast lesions.
Mammi has the ability to detect early lesions with more accuracy than other conventional methods.
Clear characterization of the lesion, provides the ability to be more treatment specific. Ideal for surgical planning and response monitoring during neoadjuvant treatments.
Before the treatment
Before the treatment